Literature DB >> 35414518

Tfh cells with NLRP3 inflammasome activation are essential for high-affinity antibody generation, germinal centre formation and autoimmunity.

Zhenhuan Zhao1, Bihua Xu2, Shuang Wang2, Mianjing Zhou2, Yuefang Huang3, Chaohuan Guo2, Mengyuan Li2, Jijun Zhao2, Sun-Sang J Sung1, Felicia Gaskin4, Niansheng Yang2, Shu Man Fu5.   

Abstract

OBJECTIVE: NLRP3 inflammasome regulates T cell responses. This study examined the roles of NLRP3 inflammasome activation in the regulation of T follicular helper (Tfh) cells during humoral response to T dependent antigens and in systemic lupus erythematosus (SLE).
METHODS: NLRP3 inflammasome activation of Tfh cells was studied in B6, MRL/lpr and NZM2328 mice and in SLE patients and healthy controls using a fluorescence-labelled caspase-1 inhibitor probe. MCC950, a selective inhibitor of NLRP3, was used to investigate the relation between NLRP3 inflammasome activation and germinal centre (GC) reaction, Ab responses to immunisation, and autoantibody production.
RESULTS: NLRP3 inflammasome activation in Tfh cells after immunisation was identified in B6 mice. MCC950 inhibited humoral responses to sheep red blood cell and NP-CGG with reduction of the GC reaction. B6 mice with lymphoid cell-specific deletion of NLRP3 or Casp1 mounted suboptimal humoral responses with impaired GC formation and defective affinity maturation. In MRL/lpr and NZM2328 mice, inhibition of NLRP3 activation suppressed NLRP3 activated Tfh cell expansion as well as attenuated lupus-like phenotypes. Tfh cells with activated NLRP3 inflammasome exhibited increased expression of molecules for Tfh cell function and differentiation, and had greater ability to activate B cells. In SLE patients, disease activity was positively correlated with an increase in the activated NLRP3+ Tfh population and this population was markedly reduced in response to therapy.
CONCLUSIONS: The activation of NLRP3 inflammasome in Tfh cells is an integral part of responses to immunisation. The activated NLRP3+ Tfh population is essential for optimal humoral responses, GC formation and autoimmunity. © Author(s) (or their employer(s)) 2022. No commercial re-use. See rights and permissions. Published by BMJ.

Entities:  

Keywords:  Autoantibodies; Autoimmunity; Inflammation; Lupus Erythematosus, Systemic; T-Lymphocyte subsets

Mesh:

Substances:

Year:  2022        PMID: 35414518      PMCID: PMC9262832          DOI: 10.1136/annrheumdis-2021-221985

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN: 0003-4967            Impact factor:   27.973


  30 in total

Review 1.  T follicular helper cell differentiation, function, and roles in disease.

Authors:  Shane Crotty
Journal:  Immunity       Date:  2014-10-16       Impact factor: 31.745

2.  Derivation of the SLEDAI. A disease activity index for lupus patients. The Committee on Prognosis Studies in SLE.

Authors:  C Bombardier; D D Gladman; M B Urowitz; D Caron; C H Chang
Journal:  Arthritis Rheum       Date:  1992-06

3.  Interferon alpha on NZM2328.Lc1R27: enhancing autoimmunity and immune complex-mediated glomerulonephritis without end stage renal failure.

Authors:  Chao Dai; Hongyang Wang; Sun-Sang J Sung; Rahul Sharma; Carol Kannapell; Wei Han; Qian Wang; Anne Davidson; Felicia Gaskin; Shu Man Fu
Journal:  Clin Immunol       Date:  2014-06-27       Impact factor: 3.969

Review 4.  Mechanism of NLRP3 inflammasome activation.

Authors:  Fayyaz S Sutterwala; Stefanie Haasken; Suzanne L Cassel
Journal:  Ann N Y Acad Sci       Date:  2014-05-19       Impact factor: 5.691

5.  The measurement of relative antibody affinity by ELISA using thiocyanate elution.

Authors:  R A Macdonald; C S Hosking; C L Jones
Journal:  J Immunol Methods       Date:  1988-02-10       Impact factor: 2.303

6.  An essential role of caspase 1 in the induction of murine lupus and its associated vascular damage.

Authors:  J Michelle Kahlenberg; Srilakshmi Yalavarthi; Wenpu Zhao; Jeffrey B Hodgin; Tamra J Reed; Noriko M Tsuji; Mariana J Kaplan
Journal:  Arthritis Rheumatol       Date:  2014-01       Impact factor: 10.995

7.  Receptor interacting protein kinase-3 determines cellular necrotic response to TNF-alpha.

Authors:  Sudan He; Lai Wang; Lin Miao; Tao Wang; Fenghe Du; Liping Zhao; Xiaodong Wang
Journal:  Cell       Date:  2009-06-12       Impact factor: 41.582

8.  RIPK3 promotes cell death and NLRP3 inflammasome activation in the absence of MLKL.

Authors:  Kate E Lawlor; Nufail Khan; Alison Mildenhall; Motti Gerlic; Ben A Croker; Akshay A D'Cruz; Cathrine Hall; Sukhdeep Kaur Spall; Holly Anderton; Seth L Masters; Maryam Rashidi; Ian P Wicks; Warren S Alexander; Yasuhiro Mitsuuchi; Christopher A Benetatos; Stephen M Condon; W Wei-Lynn Wong; John Silke; David L Vaux; James E Vince
Journal:  Nat Commun       Date:  2015-02-18       Impact factor: 14.919

9.  A small-molecule inhibitor of the NLRP3 inflammasome for the treatment of inflammatory diseases.

Authors:  Rebecca C Coll; Avril A B Robertson; Jae Jin Chae; Sarah C Higgins; Raúl Muñoz-Planillo; Marco C Inserra; Irina Vetter; Lara S Dungan; Brian G Monks; Andrea Stutz; Daniel E Croker; Mark S Butler; Moritz Haneklaus; Caroline E Sutton; Gabriel Núñez; Eicke Latz; Daniel L Kastner; Kingston H G Mills; Seth L Masters; Kate Schroder; Matthew A Cooper; Luke A J O'Neill
Journal:  Nat Med       Date:  2015-02-16       Impact factor: 53.440

10.  Interleukin 1 enhances T-dependent immune responses by amplifying the function of dendritic cells.

Authors:  S L Koide; K Inaba; R M Steinman
Journal:  J Exp Med       Date:  1987-02-01       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.